Abstract
Photocleavable protecting groups hold great promise in photopharmacology to control the release of bioactive molecules from their caged precursors within specific subcellular compartments. Herein, we describe a series of photocages based on a COUPY scaffold, incorporating chlorambucil (CLB) and 4-phenylbutyric acid (4-PBA) as bioactive payloads that can be efficiently activated with visible light. Confocal microscopy confirmed the preferential accumulation of CLB and 4-PBA N-hexyl COUPY photocages in the mitochondria, which exhibited a remarkable phototoxicity against cancer cells upon green-yellow light irradiation, with IC50 values in the nanomolar range. This effect was attributed to a synergistic mechanism involving the photorelease of the bioactive payloads and the intrinsic photogeneration of Type I and Type II ROS by the COUPY scaffold within mitochondria. Thus, COUPY-caged derivatives of CLB and 4-PBA underscore the potential of COUPY-caging groups as a versatile platform to develop innovative light-activated agents operating simultaneously through photodynamic therapy and photoactivated chemotherapy.
Funding Information
  • Ministerio de Ciencia, Innovaci?n y Universidades (IJC2020-043482-I, PID2020-117508RB-I00, PID2020-120499RB-I00, PID2023-146161OB-I00, PID2023-152950OB-I00)
  • Anusandhan National Research Foundation (SIR/2022/000895)
  • European Regional Development Fund (PID2020-117508RB-I00, PID2020-120499RB-I00, PID2023-146161OB-I00, PID2023-152950OB-I00)
  • NextGenerationEU
  • Generalitat de Catalunya (2021 SGR 00508)
  • Universitat de Barcelona

This publication has 82 references indexed in Scilit: